Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease
Dr. Franziska Hopfner talks about the main takeaways from her paper on the use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.
9 Heinä 20191min
First Cannabis-Derived Pharmaceutical
Dr. Jerzy Szaflarski talks about the FDA's approval of the first cannabis-derived pharmaceutical for the treatment of epilepsy and Lennox-Gastaut syndrome in particular. For more, read the full articl...
8 Heinä 20191min
Sports Concussion Conference 2019
Co-director Dr. Brian Hainline talks about new features and highlights of the 2019 AAN Sports Concussion Conference. The conference takes place July 26-28 in Indianapolis.
5 Heinä 20192min
Continuum Pearls: Pregnancy and Family Planning in MS, pt. 2
Dr. Annette Langer-Gould discusses pregnancy and family planning with MS in the second part of a three-part series. To learn more, read the article "Pregnancy and Family Planning in Multiple Sclerosis...
4 Heinä 20192min
Continuum Pearls: Pregnancy and Family Planning in Multiple Sclerosis, pt. 1
Dr. Annette Langer-Gould discusses pregnancy and family planning with MS in the first of a three-part series. To learn more, read the article "Pregnancy and Family Planning in Multiple Sclerosis" by D...
3 Heinä 20191min
Current treatment practice of Guillain-Barré syndrome
Dr. Michelle Mauermann talks with Dr. Bart Jacobs about his paper on current treatment practice of Guillain-Barré syndrome.
2 Heinä 20191min
Somatic expansion of the C9orf72 repeat
Dr. Guy Rouleau discusses the main takeaways from his Neurology: Genetics paper on how the somatic expansion of the C9orf72 Hexanucleotide repeat does not occur in ALS spinal cord tissues.
1 Heinä 20191min
Brian Dodick discusses the 2019 Sports Concussion Conference
Dr. Brian Dodick discusses highlights of the upcoming 2019 Sports Concussion Conference in Indianapolis.
28 Kesä 20192min
